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1. introduction 
Epidermal growth factor (EGF), a polypeptide first 
isolated from submaxillary glands [1,2], was found 
identical to urogastrone, a polypeptide prepared from 
urine [3,4]. Both substances inhibit gastric acid secre- 
tion, [4,5] stimulate the growth of various cells in 
culture [6-141, and are powerful mitogens causing 
epithelial proliferation and kerat~i~tion of squamous 
epithelial cells in vivo [7]. EGF, like a polypeptide 
hormone,acts on its target-cells via specific membrane 
receptors [8,9,14-191. The facts that the normal 
epithelial cells of the intestine are in rapid proliferation 
[20], and that EGF-urogastrone is present in the 
small intestine [21,22] induced us to test the first step 
of action of this peptide in isolated intestinal epithe~a1 
cells. Here we show the presence of high affinity bind- 
ing sites specific for EGF-urogastrone in isolated rat 
intestinal epithelial cells. The existence of such recep- 
tors is a strong argument for the action of EGF-uro- 
gastrone at the level of normal intestinal epithelial cell. 
2. Materials and methods 
Mouse EGF was a kind gift of Novo Res. Inst. 
(Copenhagen) and was prepared asin [23]. Monocom- 
ponent pork insulin was purchased from Novo, fatty 
acid free bovine serum albumin was from Sigma(M0). 
Carrier-free Naz2’I (EMS-300) was from the Radio- 
chemical Centre (Amersham). All chemicals were of 
reagent grade. 
Rat intestinal epithelial cells from the jejuno-ileum 
of female Sprague-Dawely rats (1 SO-200 g), fed ad 
ElsevierJMorth-Holland ~iomedi&~l Press 
libitum, were isolated by hand shaking in a dispersing 
solution containing EDTA (2 S mM) as in 1241; con- 
tent, 0.24 mg cell protein/ 1 O6 cells [24]. EGF was 
iodinated by the chloramin T method and purified on 
Sephadex G-50 as for insulin [25]. The specific activity 
was -160 &i/@g, i.e., 0.4 atoms iodine/molecule as a 
mean.Binding studies were performed in Krebs Ringer 
phosphate buffer (pH 7.4) containing 1% bovine serum 
albumin, [i2’I]EGF (-6 - 10-l’ M), and when indi- 
cated, increasing concentrations of unlabelled EGF. 
After incubation, the cell-bound radioactivity was 
separated by a rapid centrifugation as for insulin 
binding [26] and counted in a gamma spectrometer. 
Values are reported as specific binding: this is obtained 
by subtracting from the total the non-specific binding, 
i.e., the amount of [r2’I]EGF that is not displaced by 
lo-’ M unlabelled EGF. For dissociation studies, cell- 
bound. radioactivity was separated by filtration on 
glass fiber filters as for insulin [27]. The integrity of 
EGF in the incubation medium was tested by its abil- 
ity to bind to rat liver plasma membranes a  for insulin 
1281. Except for fig.4, the results are expressed as 
means of duplicate or trip~cate determinations. Each 
individual value differed by <IO%. 
3. Results and discussion 
Fig.l(left) shows the time course of association of 
[i2’I]EGF to rat intestinal epithelial cells at 20 and 
3O*C. The binding is time- and temperaturedepen- 
dent, the equilibrium being achieved in 30 min at 
20°C and 15 mm at 3O’C. Non-specific binding 
accounted for 20-25% and 40-45% of total binding 
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Fig.1. Left: time curves of [ “‘I]EGF specific binding to rat 
intestinal epithehal cells at 30°C (0) and 20°C (a). Cells 
(1 mg ceII protein/ml) were incubated with 8.4 . 10‘” M 
[ rz51]EGF for the times indicated on the abscissa. Right: dis- 
sociation of bound [ ‘Z51]EGF to rat intestinal epithelial cells 
at 2O”C, initiated by dilution (X 20) of the incubation 
medium. Cells {0.66 mg celI prote~/ml) were incubated for 
30 min at 2O”C, and the specific binding determined; this 
corresponds to 100% on the ordinate (time 0 of dissociation). 
After dilution, the specific binding was determined by fiitra- 
tion at the times indicated on the abscissa. 
at 20 and 30°C, respectively. Binding is higher at 
20°C and all subsequent studies were performed at 
this temperature. Fig.l(right) shows the dissociation, 
at 20°C, of bound [r2’I]EGF to the cells by dilution 
of the medium of incubation (X20). 50% of bound 
[“‘I]EGF is dissociated in 25 min, and -40% 
remained associated after 60 mm. No further dissocia- 
tion is obtained after 120 min. f’251]EGF is not 
degraded in the medium neither at 20 nor at 3O*C 
after 1 h incubation with intestinal epithelial cells 
(0.76 mg/ml). Similarly,no degradation of the peptide 
could be detected after 30 min at 20°C even in the 
presence of 2 mg cell protein/ml (not shown). This 
absence of degradation of the peptide was found also 
in the presence of rat Iiver and placental membranes 
[ 1.51. On the contrary, as shown in fig.2, the binding 
sites are rapidly inactivated by preincubation of the 
cells at 20 or 30°C before adding the 1251-labelled 
peptide. The inactivation concerns 50% of the sites 
after 35 and 10 mm at 20 and 3O”C, respectively 
(fig.2). The stronger inactivation of binding sites at 
30°C as compared to 20°C can explain at least in part 
the fact that binding islower at 30 than at 20°C (fig.1, 
left). The binding of [“‘I]EGF to rat intestinal epi- 
thelial cells is proportional to [cell protein] up to 
2 mg/ml (tig.3). Fig.4(left) shows the competition 
01..,.., 
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Fig.2. Time curves of inactivation of binding sites. Cells 
(1 mg cell protein/ml) were preincubated without EGF for 
the times indicated on the abscissa t 20°C (*) and 3O’C (0). 
Then 8 .10-r’ M [ *z51]EGF was added, the incubation con- 
tinued for 30 min at 20°C and the specific binding determined. 
Fig.3. Specific binding of [ ‘?]EGF as a function of [cell 
protein]. Cells (0.4-2.14 mg ceil protein/ml) were incubated 
at the different concentrations indicated on the abscissa with 
8.4 . IO-” M [1251]EGF for 30 min at 20°C. 
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Fig.4. Concentration dependence of EGF binding. Left: inhi- 
bition of binding of [‘*‘I]EGF by unlabelled EGF. Right: 
total binding as function of total EGF concentration. Cells 
(0.5-l .5 mg cell protein/ml) were incubated for 30 min at 
20°C with [‘*‘I]EGF (6-8 . 10-r’ M) in the absence (left: 
100% on the ordinate) and presence of increasing concentra- 
tion of unlabelled EGF (8 . lo-” to 2 . lo-’ M). Each value 
is the mean of 3-6 separate xpt. performed in duplicate. 
between [rZSI]EGF and unlabelled EGF. Unlabelled 
EGF inhibits competitively tracer binding in the range 
of 8 . lo-” to 2 . lOa M. Half maximum inhibition 
is obtained with 7 . 10-r’ M unlabelled peptide. The 
saturation of binding sites is attained with lOa M 
EGF (fig .4, right). As calculated from the curve, the 
total number of binding sites is 1.26 . lO”/mg cell 
protein, i.e ., 3000 sites/cell. This amount of EGF 
bound at saturation is comparable with the amount 
bound to human fibroblasts [8], a target-cell for EGF 
[6,10]. As calculated from fig.4(right) the apparent 
K, = lo-’ M ,as found for rat liver plasma membranes 
[ 151 and human fibroblasts [6]. Insulin, at 10” M 
did not compete with [12’1]EGF for the binding site, 
as found in other tissues [ 151. These results show the 
presence of specific EGF receptors in intestinal epi- 
thelial cells. The characteristics of these EGF receptors 
are compatible with the physiological involvements of 
EGF-urogastrone in the control of the function of 
intestinal epithelium: in regard to the powerful mito- 
genie action of EGF [ 11, further studies should inves- 
tigate its eventual effects on the control of growth of 
the rapidly proliferating intestinal epithelium, and its 
interaction with the insulin [27] and VIP [24] recep- 
tors described in these cells. 
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